Tag results for: LILLY DRN
Thursday’s big stock stories: What’s likely to move the market in the next trading session
The major averages posted modest gains on Wednesday, with the S&P 500 closing at another record. Here's what's on CNBC's radar going into Thursday.
Source link
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Steve Christo | Corbis News | Getty ImagesA version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your...
Friday’s big stock stories: What’s likely to move the market in the next trading session
President Donald Trump held off on enacting reciprocal tariffs for now, which helped lift stocks on Thursday. Here's what CNBC is watching going into Friday.
Source link
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Eli Lilly on Thursday reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared.The company's quarterly...
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty ImagesEli Lilly...
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | ReutersThe Biden administration on Friday unveiled the next...
